-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Marked effect of milnacipran combined with olanzapine for a delusional depressive patient
(2064) Views (340) Full article downloads
Authors: Yuka Sugawara, Hisashi Higuchi, Keizo Yoshida, Tetsuo Shimizu
Published Date February 2005
Volume 2005:1(4) Pages 373 - 374
DOI: http://dx.doi.org/10.2147/NDT.S
Yuka Sugawara1, Hisashi Higuchi2, Keizo Yoshida1, Tetsuo Shimizu1
1Department of Psychiatry, Akita University School of Medicine, Akita, Japan; 2Omagari City Hospital, Akita, Japan
Abstract: This report is the first to describe the use of milnacipran and olanzapine in combination in the treatment of delusional depression. The patient was a 55-year-old woman, and the combination treatment brought her marked amelioration of delusional depression without significant side effects. This suggests that the combination therapy of milnacipran and olanzapine is efficacious and safe in the treatment of delusional depression.
Keywords: combination therapy, delusional depression, milnacipran, olanzapine
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
- Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
- Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
- Moderate alcohol consumption and cognitive risk
